| Investigator |
Title |
Sponsor |
ID |
Dates |
Amount |
| Michael P Jankowski, PHD |
Understanding Chemotherapy Failure in AML: Resistance Mechanisms to a Nanoparticle Chemotherapy Delivery System |
National Institutes of Health (NIH) |
R01NS105715 |
3/1/22-2/28/23 |
$410,648 |
| Vidya Chidambaran, MD |
Investigating the role of ovar |
National Institutes of Health (NIH) |
R01AR075857 |
8/1/21-7/31/22 |
$585,931 |
| Christin Godale |
COG Autopsy Initiative |
National Institutes of Health (NIH) |
F31NS115525 |
12/1/21-11/30/22 |
$38,717 |
| Michael P Jankowski, PHD |
One carbon and nucleotide meta |
National Institutes of Health (NIH) |
R61AR078060 |
8/1/21-7/31/23 |
$385,575 |
| Michael P Jankowski, PHD |
Therapeutic Blockade of Metabo |
National Institutes of Health (NIH) |
R01NS113965 |
9/1/21-8/31/22 |
$488,774 |
| Rachel M Thienprayoon, MD |
Training Grant |
Parent Project Muscular Dystrophy |
PPMD - Thienprayoon, |
4/1/21-3/31/22 |
$82,313 |
| Jamie W Sinton, MD |
PBTC-060: A Pilot Study of Saf |
National Institutes of Health (NIH) |
R21HL162572 |
9/17/21-6/30/23 |
$421,134 |
| Cheryl J Hartzell, MD |
Phase 1 Trial of Autologous HE |
Society for Pediatric Anesthesia |
Peds Anest - Hartzel |
1/1/22-12/31/22 |
$49,985 |
| Michael P Jankowski, PHD |
Children's Oncology Group Pedi |
US Army/Henry M. Jackson Foundation |
1023994 |
11/15/21-6/30/22 |
$35,440 |
| Steve Danzer, PHD |
Targeting MBNL1-mediated alter |
National Institutes of Health (NIH)/Ntl Inst of Neuro Disorders & Stroke |
R01NS121042 |
12/15/21-11/30/22 |
$492,803 |
| Total Annual Grant Award Dollars |
$2,991,320 |
